PT3820529T - Solubilizado com curcumina e pelo menos o canabinoide thc como uma substância ativa adicional - Google Patents

Solubilizado com curcumina e pelo menos o canabinoide thc como uma substância ativa adicional

Info

Publication number
PT3820529T
PT3820529T PT197367352T PT19736735T PT3820529T PT 3820529 T PT3820529 T PT 3820529T PT 197367352 T PT197367352 T PT 197367352T PT 19736735 T PT19736735 T PT 19736735T PT 3820529 T PT3820529 T PT 3820529T
Authority
PT
Portugal
Prior art keywords
curcuminin
solubilisate
active agent
further active
cannabinoid thc
Prior art date
Application number
PT197367352T
Other languages
English (en)
Original Assignee
Aquanova Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2018/068731 external-priority patent/WO2019011955A2/de
Application filed by Aquanova Ag filed Critical Aquanova Ag
Publication of PT3820529T publication Critical patent/PT3820529T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
PT197367352T 2018-07-11 2019-07-10 Solubilizado com curcumina e pelo menos o canabinoide thc como uma substância ativa adicional PT3820529T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2018/068731 WO2019011955A2 (de) 2017-07-11 2018-07-11 Solubilisat mit curcumin und optional zumindest einem weiteren wirkstoff

Publications (1)

Publication Number Publication Date
PT3820529T true PT3820529T (pt) 2023-10-26

Family

ID=67180795

Family Applications (2)

Application Number Title Priority Date Filing Date
PT197364045T PT3820528T (pt) 2018-07-11 2019-07-10 Solubilizado com curcumina e pelo menos um canabinoide como substância ativa adicional
PT197367352T PT3820529T (pt) 2018-07-11 2019-07-10 Solubilizado com curcumina e pelo menos o canabinoide thc como uma substância ativa adicional

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT197364045T PT3820528T (pt) 2018-07-11 2019-07-10 Solubilizado com curcumina e pelo menos um canabinoide como substância ativa adicional

Country Status (11)

Country Link
EP (2) EP3820529B1 (pt)
JP (2) JP2021524488A (pt)
KR (2) KR102659259B1 (pt)
CN (2) CN112469444A (pt)
BR (2) BR112020026393A2 (pt)
CA (2) CA3102663A1 (pt)
FI (1) FI3820529T3 (pt)
HR (1) HRP20231263T1 (pt)
PL (1) PL3820528T3 (pt)
PT (2) PT3820528T (pt)
WO (2) WO2020011854A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4275694A1 (de) 2022-05-13 2023-11-15 Solmic Biotech GmbH Verwendung von solubilisaten in erzeugnissen zur topischen anwendung
WO2023139101A1 (de) 2022-01-20 2023-07-27 Solmic Biotech GmbH Maske für medizinische oder kosmetische zwecke mit mizellierten extrakten
WO2023250211A2 (en) * 2022-06-24 2023-12-28 Veroscience Llc Treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease
WO2024149451A1 (de) * 2023-01-11 2024-07-18 Aquanova Ag Cannabinoidsolubilisat

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695661A5 (de) * 2001-03-06 2006-07-31 Forsch Hiscia Ver Fuer Krebsfo Pharmazeutische Zusammensetzung.
US7279185B2 (en) 2001-10-26 2007-10-09 Metaproteonics, Llc Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
ATE321124T1 (de) * 2002-12-18 2006-04-15 Doehler Gmbh Xanthohumol-haltiges getränk
JP2005179213A (ja) 2003-12-17 2005-07-07 Kaneka Corp 肝臓障害抑制作用組成物とその製造方法
JP2009514890A (ja) * 2005-11-07 2009-04-09 マーティ・ファーマシューティカルズ・インク テトラヒドロカンナビノールの改良された送達
WO2008120220A1 (en) 2007-04-03 2008-10-09 Ganga Raju Gokaraju Synergistic anti-inflammatory and antioxidant dietary supplement compositions
CN103298443B (zh) * 2011-01-06 2015-06-17 花王株式会社 水包油型乳化组合物
CN103861090B (zh) * 2012-12-18 2017-06-13 美迪思生物科技(北京)有限公司 含蛋白或多肽的疏水溶液、其制备方法及用途
DE202012012130U1 (de) * 2012-12-19 2014-03-21 Aquanova Ag Curcuminsolubilisat
WO2015171445A1 (en) * 2014-05-06 2015-11-12 Mewa Singh Pharmaceutical compositions comprising hemp and turmeric to treat pain and inflammation
WO2016022936A1 (en) * 2014-08-07 2016-02-11 Murty Pharmaceuticals, Inc. An improved oral gastrointestinal dosage form delivery system of cannabinoids and/or standardized marijuana extracts
US20160081975A1 (en) * 2014-09-18 2016-03-24 Virun, Inc. Soft gel compositions and pre-gel concentrates
US20180280464A1 (en) * 2015-10-15 2018-10-04 Preleve Therapeutics, Llc Compositions and Methods for Pain Relief
JP6781974B2 (ja) 2016-03-31 2020-11-11 国立大学法人 宮崎大学 アドレノメデュリン凍結乾燥製剤の製造方法
IL248149B (en) * 2016-09-29 2020-03-31 Garti Nissim Formulations of dilutable cannabinoids and processes for their preparation

Also Published As

Publication number Publication date
PT3820528T (pt) 2023-10-26
WO2020011854A1 (de) 2020-01-16
CN112469444A (zh) 2021-03-09
CA3102663A1 (en) 2020-01-16
JP7254898B2 (ja) 2023-04-10
EP3820528B1 (de) 2023-08-30
JP2021524271A (ja) 2021-09-13
KR20210032424A (ko) 2021-03-24
WO2020011855A1 (de) 2020-01-16
EP3820528A1 (de) 2021-05-19
PL3820528T3 (pl) 2024-01-29
HRP20231263T1 (hr) 2024-02-02
BR112020026362A2 (pt) 2021-03-30
JP2021524488A (ja) 2021-09-13
EP3820529B1 (de) 2023-08-23
BR112020026393A2 (pt) 2021-03-23
KR102659259B1 (ko) 2024-04-23
CN112533638A (zh) 2021-03-19
CA3103354A1 (en) 2020-01-16
EP3820529A1 (de) 2021-05-19
FI3820529T3 (en) 2023-09-29
KR20210032423A (ko) 2021-03-24

Similar Documents

Publication Publication Date Title
IL278224A (en) Preparations of cannabidiol and their uses
ZA201905054B (en) Electrosurgical energy conveying structure and electrosurgical device incorporating the same
GB202002677D0 (en) Beamed elastomeric laminate structure, fit, and textute
IL256455B (en) Phenoxyhalogenphenylamidines and the use thereof as fungicides
PT3820529T (pt) Solubilizado com curcumina e pelo menos o canabinoide thc como uma substância ativa adicional
RS64636B1 (sr) Solubilizat sa kurkuminom i bar kanabinoidom thc-om kao daljim aktivnim sastojkom
GB201712273D0 (en) The P.I.R. Co. Ltd - business model
EP3768592C0 (en) STRUCTURE CONSTRUCTION FOR AIRCRAFT AND AIRCRAFT INCLUDING STRUCTURE CONSTRUCTION
IL278881A (en) Cannabinoids and their use
IL267184A (en) Phenylamidines and the use thereof as fungicides
IL287929A (en) Cannabinoids and their uses
GB201909462D0 (en) eMeas and MDT
GB2562080B (en) A fungicidal composition and the use thereof
IL267258A (en) Phenoxyphenylamidines and the use thereof as fungicides
IL289531A (en) cd38 binding agents and uses thereof
IL288828A (en) Binding factors - cd38 and their use
IL280369A (en) Myokines and their uses
EP3701119B8 (en) Well design and associated well structures
EP3703805A4 (en) MAGNETICALLY ASSISTED ADMINISTRATION IN AND THROUGH THE SKIN
KR102219947B9 (ko) 촉매 및 이를 포함하는 전극
EP3634475A4 (en) REDUCTION OF AGROBACTERIUM ENDOTOXIN TOXICITY
PL3358118T3 (pl) Zespół progu i próg
IL287503A (en) Thio-semicarbazide compounds and their use
GB201917427D0 (en) The flylead
GB201916822D0 (en) The degravitator